Scientists use yellow fever vaccine to map immune System's battle plan
NCT ID NCT00694655
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study gave 239 healthy adults the yellow fever vaccine to learn how the immune system fights viral infections. Researchers measured the strength and quality of T cell responses over up to one year. The goal was to understand immune reactions, not to test the vaccine itself, which is already approved and safe.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for YELLOW FEVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Hope Clinic of the Emory Vaccine Center
Decatur, Georgia, 30030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New yellow fever vaccine shows promise in Mid-Stage trial
- New vaccines for yellow fever and rabies enter first human tests
- New yellow fever vaccine shows promise in early human trial
- 10,000 people tested: Cambodia's massive disease hunt begins
- New yellow fever vaccine shows promise in early safety trial
- New yellow fever vaccine shows promise in japanese adults